Tirzepatide 60mg

Tirzepatide — 60 mg

Dual GIP & GLP-1 Receptor Agonist

Tirzepatide is a synthetic peptide studied for its dual activity at glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This dual-receptor mechanism has made tirzepatide an important subject of metabolic research involving energy balance, glucose regulation, appetite signaling, and body-weight regulation.

Research has demonstrated that activation of these incretin pathways can influence several interconnected metabolic processes, including glucose-dependent insulin signaling, glucagon regulation, gastric emptying, satiety signaling, appetite, and food intake. Tirzepatide has also been extensively investigated clinically for its effects on glycemic control and body-weight reduction.

Key Areas of Research

• Dual GIP and GLP-1 receptor agonist activity
• Appetite and satiety signaling
• Food-intake and energy-balance regulation
• Glucose metabolism and glycemic control
• Insulin and glucagon signaling
• Metabolic and body-weight regulation

Product Strength: 60 mg

FOR RESEARCH USE ONLY